Analyst Reco. Surgery Partners, Inc.

Equities

SGRY

US86881A1007

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
24.55 ^USD	-1.17%		+3.02%	-23.26%

03-26	Surgery Partners Unit to Offer $600 Million of Senior Notes	MT
03-06	Surgery Partners Insider Sold Shares Worth $277,633, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Surgery Partners to $49 From $47, Keeps Outperform Rating	01-24	MT
Optimism Over Potential Upcoming Interest Rate Cuts Drives Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday	12-15	MT
TD Cowen Upgrades Surgery Partners to Outperform From Market Perform, Cuts Price Target to $35 From $39	11-14	MT
Barclays Adjusts Price Target on Surgery Partners to $51 From $56, Maintains Overweight Rating	23-08-02	MT
Mizuho Adjusts Price Target on Surgery Partners to $50 From $48, Maintains Buy Rating	23-07-11	MT
BofA Securities Upgrades Surgery Partners to Buy From Neutral, Adjusts Price Target to $45 From $42	23-06-02	MT
Mizuho Starts Surgery Partners at Buy With $48 Price Target	23-05-12	MT
Citigroup Adjusts Price Target on Surgery Partners to $47 From $40, Maintains Buy Rating	23-05-02	MT
Cantor Fitzgerald Initiates Surgery Partners at Overweight With $43 Price Target	23-04-21	MT
RBC Trims Price Target on Surgery Partners to $47 From $48, Maintains Outperform Rating	23-03-03	MT
Barclays Adjusts Price Target on Surgery Partners to $56 From $69, Maintains Overweight Rating	23-01-18	MT
Benchmark Adjusts Price Target on Surgery Partners to $47 From $60, Maintains Buy Rating	22-12-05	MT
RBC Cuts Price Target on Surgery Partners to $48 From $58, Citing Pro Forma Capital Structure, Maintains Outperform Rating	22-11-23	MT
SVB Securities Adjusts Price Target on Surgery Partners to $40 From $55, Maintains Outperform Rating	22-11-22	MT
SVB Securities Adjusts Price Target on Surgery Partners to $55 From $57, Maintains Outperform Rating	22-11-10	MT
RBC Cuts Price Target on Surgery Partners to $58 From $62, Noting Sequentially Higher Net Debt, Maintains Outperform Rating	22-11-10	MT
Citigroup Cuts Price Target on Surgery Partners to $38 From $49, Maintains Buy Rating	22-11-09	MT
RBC Cuts Price Target on Surgery Partners to $62 From $65, Maintains Outperform Rating	22-08-03	MT
BofA Securities Downgrades Surgery Partners to Neutral From Buy	22-06-15	MT
SVB Leerink Adjusts Surgery Partners' Price Target to $65 from $63, Keeps Outperform Rating	22-03-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Surgery Partners, Inc.

Equities

SGRY

US86881A1007

Analyst Reco.

Filters